- Immunotherapy biomarkers review. Apr 13, 2023 · Established cancer biomarkers and response to immunotherapy We also investigated the power of established cancer biomarkers for predicting therapeutic response to immune checkpoint inhibitors. May 18, 2022 · We reviewed published data regarding biomarkers that have been approved by the United States Food and Drug Administration as well as experimental tissue and peripheral blood biomarkers currently under investigation. Sep 9, 2024 · Immunotherapy has been advanced through multiple approaches, including immunogenic cytokines, monoclonal antibodies, therapeutic vaccinations, adoptive cell transfer, stem cell transplantation, and oncolytic viruses. This review provides up‐to‐date information on the evolving field of currently available biomarkers in predicting immunotherapy. Oct 5, 2025 · The 10 review and research articles included in this issue (see Table 1) contribute to extending our knowledge on several aspects of tumor immunology and immunotherapy, which may help with the rational development of next-generation immunotherapies and combinatorial approaches. discuss the limitations of current predictive biomarkers of response to immune checkpoint inhibitors and the need to further explore static, dynamic and patient Apr 15, 2020 · The purpose of this review is to highlight the role of ICIs in patients with advanced NSCLC and past or current studies in potential biomarkers as well as future directions on the role of imaging in immunotherapy. Sep 19, 2022 · In this article, we describe the efforts to manipulate the immune system against cancer and discuss different targets and cell types that can be exploited to promote the antitumor immune May 19, 2016 · This review focuses on the development of biomarkers for immunotherapy at the soluble, cellular, and genomic levels. This review provides up-to-date information on the evolving field of currently available biomarkers in predicting immunotherapy. . New predictive biomarkers of ICI response are needed to improve patient selection for treatment. 7l8 smgd trx 6k1k ggnk3 h0nxwl uay49 m41q3v jnl sniqcyj
